AGM/EGMApr 29, 2026, 04:38 PM
DNA 2026 AGM on June 11; Director Election, Auditor Ratification
AI Summary
Ginkgo Bioworks Holdings, Inc. announced its 2026 Annual Meeting of Shareholders will be held virtually on Thursday, June 11, 2026, at 8:00 a.m. Eastern Time. Shareholders of record as of April 15, 2026, are eligible to vote on proposals including the election of six director nominees, the ratification of Deloitte & Touche LLP as the independent registered public accounting firm, and an advisory vote on executive compensation. Current Board Chair Shyam Sankar is not seeking re-election, leading to a reduction in board size from seven to six directors, and Ross Fubini is expected to chair the Compensation Committee.
Key Highlights
- 2026 Annual Meeting of Shareholders scheduled for June 11, 2026, at 8:00 a.m. ET.
- Meeting will be virtual-only, accessible at www.virtualshareholdermeeting.com/DNA2026.
- Shareholders of record as of April 15, 2026, are entitled to vote.
- Proposals include the election of six director nominees to the Board.
- Ratification of Deloitte & Touche LLP as independent auditor for fiscal year 2026.
- Advisory vote to approve executive compensation will be conducted.
- Shyam Sankar is not standing for re-election; Board size will decrease from seven to six directors.
- Ross Fubini is expected to serve as chairperson of the Compensation Committee after the AGM.